2.0
4. Juni 2023
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
One of a kind, lucrative, and innovative surgical product for minimally invasive prostrate surgery. Hard working cross functional teams and dedicated staff at all levels.
Kontras
Chaotic strategy and business planning. Shared resources between sustaining and NPI projects. Horrible work life balance. All departments are resource constrained. Subpar compensation/benefits compared to similar Bay Area companies. High attrition rate.